Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-06-02
1997-09-09
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546193, 546194, A61K 31445, C07D21122, C07D21126, C07D21132
Patent
active
056657358
ABSTRACT:
Disclosed is a compound of Formula 1.0: ##STR1## or a pharmaceutically acceptable salt or solvate thereof, wherein: AR.sup.1 represents ##STR2## AR.sup.2 represents ##STR3## or a five-membered heterocyclic aromatic group selected from the group consisting of Formulas I to XII, wherein the substitutable carbon atoms of the five-membered heterocyclic group can optionally be substituted with a group R.sup.1.
Also disclosed are pharmaceutical compositions containing compounds of Formula 1.0.
Further disclosed is a method for treating asthma, allergy and inflammation by administering an anti-asthmatic, anti-allergic or anti-inflammatory, respectively, effective amount of a compound of Formula 1.0.
REFERENCES:
patent: 2739968 (1956-03-01), Sperrer et al.
patent: 2898339 (1959-08-01), Wheeler et al.
patent: 3325501 (1967-06-01), Ettinsen
patent: 3326924 (1967-06-01), Villani
patent: 3717647 (1973-02-01), Villani
patent: 3803153 (1974-04-01), Villani
patent: 3803154 (1974-04-01), Drukker
patent: 3922276 (1975-11-01), Duncan, Jr. et al.
patent: 3956296 (1976-05-01), Duncan, Jr. et al.
patent: 3966944 (1976-06-01), Carter
patent: 4032642 (1977-06-01), Duncan, Jr. et al.
patent: 4105849 (1978-08-01), Hamilton et al.
patent: 4282233 (1981-08-01), Villani
patent: 4355036 (1982-10-01), Villani
patent: 4540780 (1985-09-01), Downs
patent: 4609664 (1986-09-01), Hasspacher
patent: 4628095 (1986-12-01), Rorig et al.
patent: 4632925 (1986-12-01), Mullin et al.
patent: 4659716 (1987-04-01), Villani et la.
patent: 4797489 (1989-01-01), Abou-Gharbia et al.
patent: 4826853 (1989-05-01), Piwinski et al.
patent: 4835157 (1989-05-01), Press et al.
patent: 5089496 (1992-02-01), Piwinski et al.
patent: 5151423 (1992-09-01), Piwinski et al.
patent: 5166205 (1992-11-01), Cuberes-Altisent et al.
patent: 5432175 (1995-07-01), Piwinski
Villani et al., Journal of Medicinal Chemistry, vol. 15, No. 7, pp. 750-754 (1972).
Arzn. Forsh 36 1311-1314 (1986).
Galantay et al., Journal of Medicinal Chemistry, vol. 17, No. 12, pp. 1316 to 1327 (1974).
Ohtaka et al., chem. Pharm. Bull., 35(10) 4124-4129 (1987).
Kennis et al., Drug Development Research, 8:133-140 (1986).
Regnier et al., Eur. J. Med. Chem, 22(1987) 243-250.
Nishikawa et al., J. Med. Chem. 1989, 32, 583-593.
Anagnostopulos, Eur. J. Med. Chem. 24(1989) 227-232.
Ohtaka et al., Chem. Pharm. Bull, 35(8)3270-3275 (1987).
CID et al., Tetrahedron, vol. 44, No. 19, pp. 6197 to 6200 (1988).
Meyer et al., Journal of Medicinal Chemistry, 1989, vol. 32, No. 3, pp. 593-597.
Gubert et al., Azneim-Forsch./Drug Res. 37(II), Nr. 10(1987) pp. 1103-1107.
Bickel, Pharmacological Review, vol. 21, No. 4, pp. 325, and 335-336 (1969).
Wade, Jr., Organic Chemistry, p. 349, Prentice-Hall, Inc. (1987).
Friary Richard
Piwinski John J.
Wong Jesse K.
Ivy C. Warren
Jeanette Henry C.
M. Mach D. Margaret
Schering Corporation
LandOfFree
Unbridged bis-aryl carbinol derivatives compositions and methods does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Unbridged bis-aryl carbinol derivatives compositions and methods, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Unbridged bis-aryl carbinol derivatives compositions and methods will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-70298